StockData
Ionis Pharmaceuticals Inc logo

Ionis Pharmaceuticals Inc (IONS) stock

IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/303% below fair value
$26.96−1.05 (-3.75%)

Close on Nov 17, 2026Market cap $4.48BP/E –Yield –

Ionis Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Ionis Pharmaceuticals's pe ratio was 773.4× on Jan 31, 2023, against 29.2× a year earlier. Over the last 4 years it ranged from 5.6× to 791.3×, with a median of 50.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 2023773.4×+40.7
2022Dec 30, 2022732.7×+638.8
2021Jan 29, 202193.9×+5.5
2020Dec 31, 202088.3×+68.2
2019Dec 31, 201920.1×−266.7
2018Apr 30, 2018286.9×+77.3
2017Dec 29, 2017209.6×−179.7
2016Jan 29, 2016389.3×−230.0
2015Dec 31, 2015619.3×+612.5
2010Apr 30, 20106.8×–

More Ionis Pharmaceuticals figures

See a number that looks wrong?